Yesterday’s speech by Donald Trump regarding the conflict with Iran did not ease market fears, if anything, the opposite appears to be true.
Wall Street is posting significant losses across all major indices. The Russell 2000 is leading the declines, with futures down more than 2%. The S&P 500 and the Dow are holding up better, where futures are trimming losses to 1.4%.
Macroeconomic data:
- Data from the U.S. labor market has been released:
- The Challenger report shows that layoffs in the U.S. are expected to rise to 60.62k.
- Initial jobless claims came in below expectations, at 202k.
- The BEA also released foreign trade data. Imports rose to USD 372bn and exports to USD 66.31bn, resulting in a (total) trade balance of USD 57.3bn versus expectations of a USD 60.5bn deficit.
US100 (D1)
The demand side is clearly weakening, and the price remains below the EMA200, which is a strong bearish signal. In the short term, the key level for buyers is holding 23,600. If this level fails, sellers may retain full control and push the price lower, retesting the 23,000-point level.
Source: xStation5
Company news:
- Exxon (XOM.US): Oil producers and refiners are rising on expectations of higher oil prices. The stock is up 2%.
- Globalstar (GSAT.US): The Financial Times reports that Amazon intends to acquire the satellite operator. The stock is up about 15%.
- Immunovant (IMVT.US): The pharmaceutical company is down 7% after stating that two of its late-stage studies showed a lack of the expected effects from its products.
- Blue Owl (OBDC.US): More private credit funds are suspending withdrawals. The stock is down as much as 6%.
Morning Wrap: Trump want to send Iran "back to the Stone Age". Indices tumble (02.04.2026)
After Iran War: Markets and Prices
Volkswagen: Could a potential deal with Israel save the plant in Saxony?
What else might we be missing from the Persian Gulf❓
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
